Participation of interleukin-5, interleukin-8 and leukotriene B4 in eosinophil accumulation in two different experimental models.
There are several experimental models describing in vivo eosinophil (EO) migration, including ip injection of a large volume of saline (SAL) or Sephadex beads (SEP). The aim of this study was to investigate the mechanisms involved in the EO migration in these two models. Two consecutive injections of SAL given 48 hr apart, induced a selective recruitment of EO into peritoneal cavity of rats, which peaked 48 hr after the last injection. SEP, when injected ip, promoted EO accumulation in rats. The phenomenon was dose-related and peaked 48 hr after SEP injection. To investigate the mediators involved in this process we showed that BW A4C, MK 886 and dexamethasone (DXA) inhibited the EO migration induced by SAL and SEP. To investigate the source of the EO chemotactic factor we showed that mast cells, macrophages (MO), but not lymphocytes, incubated in vitro in presence of SAL released a factor which induced EO migration. With SEP, only mast cells release a factor that induced EO migration, which was inhibited by BW A4c, MK 886 and DXA. Furthermore, the chemotactic activity of SAL-stimulated mast cells was inhibited by antisera against IL-5 and IL-8 (interleukins). SAL-stimulated MO were only inhibited by anti-IL-8 antibodies as well SEP-stimulated mast cells. These results suggest that the EO migration induced by SAL may be dependent on resident mast cells and MO and mediated by LTB4, IL-5 and IL-8. SEP-induced EO migration was dependent on mast cells and may be mediated by LTB4 and IL-8. Furthermore, IL-5 and IL-8 induced EO migration, which was also dependent on resident cells and mediated by LTB4. In conclusion, EO migration induced by SAL is dependent on mast cells and MO, whereas that induced by SEP is dependent on mast cells alone. Stimulated mast cells release LTB4, IL-5 and IL-8 while MO release LTB4 and IL-8. The IL-5 and IL-8 release by the SAL or SEP-stimulated resident cells may act in an autocrine fashion, thus potentiating LTB4 release.
Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, SP, Brasil.
S H
SH
Oliveira
L H
LH
Faccioli
S H
SH
Ferreira
F Q
FQ
Cunha
D000704:Analysis of Variance; D000818:Animals; D002465:Cell Movement / Q000502:physiology*; D004195:Disease Models, Animal; D004804:Eosinophils / Q000502:physiology*; D015848:Interleukin-5 / Q000502:physiology*; D016209:Interleukin-8 / Q000502:physiology*; D007975:Leukotriene B4 / Q000502:physiology*; D008264:Macrophages; D008407:Mast Cells; D010529:Peritoneal Cavity / Q000166:cytology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology
D015848:Interleukin-5; D016209:Interleukin-8; D007975:Leukotriene B4; D012965:Sodium Chloride